Becton Dickinson BDX
NYSE BDX
$192.00 +4.38 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Becton Dickinson (BDX) Net Equity Issued and Repurchased (2017)

Becton Dickinson (BDX) posted quarterly Net Equity Issued and Repurchased of $4.8 billion for Q2 2017.

Becton Dickinson (BDX) Net Equity Issued and Repurchased (2017) Analysis & Trends

Becton Dickinson (BDX) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $4.8 billion the latest figure, recorded in Q2 2017.

  • In Q2 2017, Net Equity Issued and Repurchased changed N/A year-over-year to $4.8 billion; the TTM figure through Sep 2020 stood at $4.8 billion (changed 0.0% YoY), while the FY2020 annual figure was $2.9 billion, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was little changed at $4.8 billion in Q2 2017 per BDX's latest filing.
  • Across five years, Net Equity Issued and Repurchased topped out at $4.8 billion in Q2 2017 and bottomed at $4.8 billion in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 29.31 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2017 4.80 Bn
Jun 30, 2017 4.80 Bn